#keytruda — Public Fediverse posts

https://www.europesays.com/britain/48888/ From MRC discovery research to a one-minute cancer treatment | Innovate UK #Around #biology #Cambridge #Chair #Chinnery #council #Dohme #England #Europe #Executive #Friday #Innovate #Instead #Keytruda #Laboratory #Medical #MRC #NHS #Pembrolizumab #research #UK #UnitedKingdom

https://www.europesays.com/uk/942131/ Northern Ireland Introduces New Cancer Treatment Jabs #Cancer #CancerDrug #HealthTrusts #Immunotherapy #Keytruda #NorthernIreland #pembrolizumab #UK #UnitedKingdom

Das Beispiel des #Krebsmedikaments #Keytruda (Wirkstoff #Pembrolizumab) verdeutlicht, dass die hohen Forschungskosten, mit denen die Pharmaindustrie hohe Preise begründet, oft nur vorgeschoben sind

https://www.zdfheute.de/politik/deutschland/krebs-medikament-kosten-pharmakonzerne-krankenkassen-100.html

Die Gesellschaft zahlt doppelt

https://gutepillen-schlechtepillen.de/pharmaindustrie-profit-mit-oeffentlichen-mitteln/

Das Beispiel des #Krebsmedikaments #Keytruda (Wirkstoff #Pembrolizumab) verdeutlicht, dass die hohen Forschungskosten, mit denen die Pharmaindustrie hohe Preise begründet, oft nur vorgeschoben sind

https://www.zdfheute.de/politik/deutschland/krebs-medikament-kosten-pharmakonzerne-krankenkassen-100.html

Die Gesellschaft zahlt doppelt

https://gutepillen-schlechtepillen.de/pharmaindustrie-profit-mit-oeffentlichen-mitteln/

Das Beispiel des #Krebsmedikaments #Keytruda (Wirkstoff #Pembrolizumab) verdeutlicht, dass die hohen Forschungskosten, mit denen die Pharmaindustrie hohe Preise begründet, oft nur vorgeschoben sind

https://www.zdfheute.de/politik/deutschland/krebs-medikament-kosten-pharmakonzerne-krankenkassen-100.html

Die Gesellschaft zahlt doppelt

https://gutepillen-schlechtepillen.de/pharmaindustrie-profit-mit-oeffentlichen-mitteln/

Das Beispiel des #Krebsmedikaments #Keytruda (Wirkstoff #Pembrolizumab) verdeutlicht, dass die hohen Forschungskosten, mit denen die Pharmaindustrie hohe Preise begründet, oft nur vorgeschoben sind

https://www.zdfheute.de/politik/deutschland/krebs-medikament-kosten-pharmakonzerne-krankenkassen-100.html

Die Gesellschaft zahlt doppelt

https://gutepillen-schlechtepillen.de/pharmaindustrie-profit-mit-oeffentlichen-mitteln/

Das Beispiel des #Krebsmedikaments #Keytruda (Wirkstoff #Pembrolizumab) verdeutlicht, dass die hohen Forschungskosten, mit denen die Pharmaindustrie hohe Preise begründet, oft nur vorgeschoben sind

https://www.zdfheute.de/politik/deutschland/krebs-medikament-kosten-pharmakonzerne-krankenkassen-100.html

Die Gesellschaft zahlt doppelt

https://gutepillen-schlechtepillen.de/pharmaindustrie-profit-mit-oeffentlichen-mitteln/

Global drug makers face pricing pressure as China targets affordable healthcare

Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #astrazeneca #Beijing #China #donaldtrump #EliLilly #Gardasil #Health #keytruda #Merck #Mounjaro #Roche #Sanofi #Washington
https://www.newsbeep.com/us/571163/

Global drug makers face pricing pressure as China targets affordable healthcare

Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #astrazeneca #Beijing #China #donaldtrump #EliLilly #Gardasil #Health #keytruda #Merck #Mounjaro #Roche #Sanofi #Washington
https://www.newsbeep.com/us/571163/

Global drug makers face pricing pressure as China targets affordable healthcare

Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
#NewsBeep #News #Healthcare #AstraZeneca #Beijing #China #DonaldTrump #EliLilly #Gardasil #Health #healthcare #Keytruda #merck #Mounjaro #Roche #SANOFI #UK #UnitedKingdom #UnitedStates #Washington
https://www.newsbeep.com/uk/518906/

https://www.europesays.com/uk/879345/ Global drug makers face pricing pressure as China targets affordable healthcare #AstraZeneca #Beijing #China #DonaldTrump #EliLilly #Gardasil #Health #Healthcare #Keytruda #Merck #Mounjaro #Roche #Sanofi #UK #UnitedKingdom #UnitedStates #Washington

https://www.europesays.com/ch/38457/ Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis’ Scemblix #AmyBurroughs #ChronicMyeloidLeukemia #Deals #Keytruda #MerckAcquisition #Novartis #NovartisScemblix #Pharma #PharmaceuticalM&A #TERN701 #TernsPharmaceuticals

Faut réduire la #securitesociale et fliquer les médecins qui prescrivent des arrêts maladies aux non-politiciens/miliardaires car ça coûte trop cher :

https://www.quechoisir.org/enquete-medicaments-braquage-pharmaceutique-n171088

Labo #MSD #Novartis

= pénurie de médicaments 'anciens' génériques/vieux brevêt cf #paracetamol

#sante #politique #economie #corruption #pembrolizumab #keytruda #monopole #zolgensma #vyndaqel #business

Faut réduire la #securitesociale et fliquer les médecins qui prescrivent des arrêts maladies aux non-politiciens/miliardaires car ça coûte trop cher :

https://www.quechoisir.org/enquete-medicaments-braquage-pharmaceutique-n171088

Labo #MSD #Novartis

= pénurie de médicaments 'anciens' génériques/vieux brevêt cf #paracetamol

#sante #politique #economie #corruption #pembrolizumab #keytruda #monopole #zolgensma #vyndaqel #business

Faut réduire la #securitesociale et fliquer les médecins qui prescrivent des arrêts maladies aux non-politiciens/miliardaires car ça coûte trop cher :

https://www.quechoisir.org/enquete-medicaments-braquage-pharmaceutique-n171088

Labo #MSD #Novartis

= pénurie de médicaments 'anciens' génériques/vieux brevêt cf #paracetamol

#sante #politique #economie #corruption #pembrolizumab #keytruda #monopole #zolgensma #vyndaqel #business

Faut réduire la #securitesociale et fliquer les médecins qui prescrivent des arrêts maladies aux non-politiciens/miliardaires car ça coûte trop cher :

https://www.quechoisir.org/enquete-medicaments-braquage-pharmaceutique-n171088

Labo #MSD #Novartis

= pénurie de médicaments 'anciens' génériques/vieux brevêt cf #paracetamol

#sante #politique #economie #corruption #pembrolizumab #keytruda #monopole #zolgensma #vyndaqel #business

Faut réduire la #securitesociale et fliquer les médecins qui prescrivent des arrêts maladies aux non-politiciens/miliardaires car ça coûte trop cher :

https://www.quechoisir.org/enquete-medicaments-braquage-pharmaceutique-n171088

Labo #MSD #Novartis

= pénurie de médicaments 'anciens' génériques/vieux brevêt cf #paracetamol

#sante #politique #economie #corruption #pembrolizumab #keytruda #monopole #zolgensma #vyndaqel #business

Merck’s Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy?

Merck shares began peeling back in early 2024, mostly on concerns about looming patent expirations for its breadwinning…
#NewsBeep #News #Healthcare #AU #Australia #Health #keytruda #KeytrudaQlex #Merck #patentprotection #pharmaceuticalgiant
https://www.newsbeep.com/au/339107/

https://www.europesays.com/ie/224008/ Merck’s Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy? #Éire #Health #HealthCare #Healthcare #IE #Ireland #keytruda #KeytrudaQlex #Merck #PatentProtection #PharmaceuticalGiant

🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nh ất thế giới

🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nhất thế giới 💖👉🍀🍀🤔 #ungthu #Keytruda #miendich #Merck #biosimilar #suckhoe 1️⃣ Vị thế số một của Keytruda trên thị trường toàn cầu 

Trong vòng một thập niên, Keytruda (Pembrolizumab) của Merck đã tạo nên kỷ lục hiếm có: doanh thu vượt 146 tỷ USD, trở thành thuốc ung thư bán chạy nhất thế giới.

https://tinmoitrongngay2.wordpress.com/2025/11/13/%f0%9f%8c%bf-toan-canh-keytruda-thuoc-ung-thu-ban-chay-nh-at-the-gioi-2/

🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nh ất thế giới

🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nhất thế giới 💖👉🍀🍀🤔 #ungthu #Keytruda #miendich #Merck #biosimilar #suckhoe 1️⃣ Vị thế số một của Keytruda trên thị trường toàn cầu 

Trong vòng một thập niên, Keytruda (Pembrolizumab) của Merck đã tạo nên kỷ lục hiếm có: doanh thu vượt 146 tỷ USD, trở thành thuốc ung thư bán chạy nhất thế giới.

https://tinmoitrongngay2.wordpress.com/2025/11/13/%f0%9f%8c%bf-toan-canh-keytruda-thuoc-ung-thu-ban-chay-nh-at-the-gioi/

https://www.europesays.com/es/204257/ PADCEV más KEYTRUDA mejora la supervivencia en cáncer de vejiga músculo invasivo no apto para cisplatino #afirman #apto #cáncer #cirugía #cisplatino #combinación #Ensayo #ES #ESMO #España #estándar #este #ev #Fallecimiento #frente #Health #invasivo #keynote #keytruda #mejora #mostró #muerte #musculo #no #Pacientes #padcev #podrían #presentados #progresión #recurrencia #redefinir #reduce #resultados #riesgo #Salud #sola #Spain #supervivencia #terapéutico #tipo #vejiga

Some Georgians could soon be paying double for their medications – WSB-TV Channel 2

ATLANTA — In just a matter of days, President Donald Trump’s pharmaceutical tariff …
#NewsBeep #News #Medication #AU #Australia #britney #Brittany #brittany_klein #brittney_klein_peter #channel_2 #Georgia #georgians #Health #ira_katz #Ireland #katz #keytruda #little_5 #little_5_points #Local #peter #points #president_donald_trump #president_trump #tom_smith #us #wsbsyndication
https://www.newsbeep.com/au/180198/

Merus shares hit record highs after Phase 2 data showed strong survival rates for its head and neck cancer therapy, fueling Wall Street optimism and positive analyst outlooks.
#YonhapInfomax #Merus #Keytruda #Phase2Data #SurvivalRate #SharePrice #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=66099

Merus shares hit record highs after Phase 2 data showed strong survival rates for its head and neck cancer therapy, fueling Wall Street optimism and positive analyst outlooks.
#YonhapInfomax #Merus #Keytruda #Phase2Data #SurvivalRate #SharePrice #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=66099

Merus shares hit record highs after Phase 2 data showed strong survival rates for its head and neck cancer therapy, fueling Wall Street optimism and positive analyst outlooks.
#YonhapInfomax #Merus #Keytruda #Phase2Data #SurvivalRate #SharePrice #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=66099

Merus shares hit record highs after Phase 2 data showed strong survival rates for its head and neck cancer therapy, fueling Wall Street optimism and positive analyst outlooks.
#YonhapInfomax #Merus #Keytruda #Phase2Data #SurvivalRate #SharePrice #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=66099

Merus shares hit record highs after Phase 2 data showed strong survival rates for its head and neck cancer therapy, fueling Wall Street optimism and positive analyst outlooks.
#YonhapInfomax #Merus #Keytruda #Phase2Data #SurvivalRate #SharePrice #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=66099

GI Innovation is set to sign South Korea’s first immuno-oncology technology licensing deal with Merck, potentially marking a milestone for the domestic biotech sector as talks near completion for GI-101 and GI-102 combination with Keytruda.
#YonhapInfomax #GIInnovation #Merck #ImmunoOncology #Keytruda #TechnologyTransfer #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65767

GI Innovation is set to sign South Korea’s first immuno-oncology technology licensing deal with Merck, potentially marking a milestone for the domestic biotech sector as talks near completion for GI-101 and GI-102 combination with Keytruda.
#YonhapInfomax #GIInnovation #Merck #ImmunoOncology #Keytruda #TechnologyTransfer #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65767

GI Innovation is set to sign South Korea’s first immuno-oncology technology licensing deal with Merck, potentially marking a milestone for the domestic biotech sector as talks near completion for GI-101 and GI-102 combination with Keytruda.
#YonhapInfomax #GIInnovation #Merck #ImmunoOncology #Keytruda #TechnologyTransfer #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65767

GI Innovation is set to sign South Korea’s first immuno-oncology technology licensing deal with Merck, potentially marking a milestone for the domestic biotech sector as talks near completion for GI-101 and GI-102 combination with Keytruda.
#YonhapInfomax #GIInnovation #Merck #ImmunoOncology #Keytruda #TechnologyTransfer #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65767

GI Innovation is set to sign South Korea’s first immuno-oncology technology licensing deal with Merck, potentially marking a milestone for the domestic biotech sector as talks near completion for GI-101 and GI-102 combination with Keytruda.
#YonhapInfomax #GIInnovation #Merck #ImmunoOncology #Keytruda #TechnologyTransfer #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65767

Keytruda strikes out again in endometrial cancer with phase III flop—Novo inks $600M deal with Metaphore to develop next-gen obesity drugs —Takeda Pharma to restructure after annual profit slump --http://bit.ly/w28kSd #merck #keytruda #endometrialcancer #clinicaltrials #novonordisk #obesity #drugdevelopment #takeda #restructuring #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Pembrolizumab, sold under the brand name #Keytruda, targets and blocks a specific protein on the surface of certain immune cells that then seek out and destroy the cancerous cells.
In England it is offered to those with #triple-#negative #breast #cancer, one of the most aggressive forms of the disease, which accounts for about 15% of cases.
However, new findings from a global trial suggest it could be effective when used more widely

https://www.theguardian.com/society/2024/mar/19/breast-cancer-drug-may-help-thousands-more-women?CMP=Share_iOSApp_Other

"#Moderna hofft auf #Hautkrebs-Impfstoff ab 2025

Der US-Pharmakonzern Moderna hofft, 2025 einen Impfstoff gegen schwarzen Hautkrebs auf den Markt bringen zu können. Neue Ergebnisse einer klinischen #Studie sind vielversprechend."

#Immuntherapie #Onkologie #Antikörpermedikament #Keytruda

https://www.zdf.de/nachrichten/wirtschaft/moderna-impfstoff-schwarzer-hautkrebs-100.html

“Personalized cancer vaccines are designed to prime the immune system so that a patient can generate a tailored antitumor response specific to their tumor mutation signature.” https://investors.modernatx.com/news/news-details/2022/Moderna-and-Merck-Announce-mRNA-4157V940-an-Investigational-Personalized-mRNA-Cancer-Vaccine-in-Combination-with-KEYTRUDAR-pembrolizumab-Met-Primary-Efficacy-Endpoint-in-Phase-2b-KEYNOTE-942-Trial/default.aspx

#pharmaceuticals #cancertreatment #antitumor #personalizedmedicine #moderna #merck #keytruda

Phase 2b clinical trial from Moderna & Merck using an #mRNA #cancer #vaccine + #Keytruda for a #melanoma #vaccine for stage III & IV disease reducing the risk of recurrence or death by 44% compared to Keytruda alone. Serious treatment-related adverse events occurred in 14.4% of patients who received the combination arm compared to Keytruda alone.

Phase 3 trial is planned for 2023.

https://investors.modernatx.com/news/news-details/2022/Moderna-and-Merck-Announce-mRNA-4157V940-an-Investigational-Personalized-mRNA-Cancer-Vaccine-in-Combination-with-KEYTRUDAR-pembrolizumab-Met-Primary-Efficacy-Endpoint-in-Phase-2b-KEYNOTE-942-Trial/default.aspx

Three VCs launch Dimension, a new firm with plans to fuel biotech’s ‘digitization’ — Merck's Keytruda gets a miss for prostate cancer and a hit for biliary tract cancer — Insulet reports personal-data leak of 29,000 insulin pump customers -- See more on our front page news http://bit.ly/w28kSd #venturecapital #digitization #merck #keytruda #prostatecancer #biliarytractcancer #insulet #medicaldevices #insulinpumps #dataleak #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma

"#Moderna hofft auf #Hautkrebs-Impfstoff ab 2025

Der US-Pharmakonzern Moderna hofft, 2025 einen Impfstoff gegen schwarzen Hautkrebs auf den Markt bringen zu können. Neue Ergebnisse einer klinischen #Studie sind vielversprechend."

#Immuntherapie #Onkologie #Antikörpermedikament #Keytruda

https://www.zdf.de/nachrichten/wirtschaft/moderna-impfstoff-schwarzer-hautkrebs-100.html

"#Moderna hofft auf #Hautkrebs-Impfstoff ab 2025

Der US-Pharmakonzern Moderna hofft, 2025 einen Impfstoff gegen schwarzen Hautkrebs auf den Markt bringen zu können. Neue Ergebnisse einer klinischen #Studie sind vielversprechend."

#Immuntherapie #Onkologie #Antikörpermedikament #Keytruda

https://www.zdf.de/nachrichten/wirtschaft/moderna-impfstoff-schwarzer-hautkrebs-100.html

"#Moderna hofft auf #Hautkrebs-Impfstoff ab 2025

Der US-Pharmakonzern Moderna hofft, 2025 einen Impfstoff gegen schwarzen Hautkrebs auf den Markt bringen zu können. Neue Ergebnisse einer klinischen #Studie sind vielversprechend."

#Immuntherapie #Onkologie #Antikörpermedikament #Keytruda

https://www.zdf.de/nachrichten/wirtschaft/moderna-impfstoff-schwarzer-hautkrebs-100.html

FDA approves Keytruda/Padcev combo in advanced urothelial cancer — Record growth in U.S. life sciences real estate footprint — Diabesity drugs and their free ‘contract sales force’ -- See more on our front page news http://bit.ly/w28kSd #fda #merck #astellas #urothelialcancer #realestate #diabetes #obesity #novonordisk #elililly #keytruda #lifesciences #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma